In the Life Sciences & Health Care industry, it’s crucial for organisations to balance patient needs, market opportunities and policy compliance—all while innovating. Deloitte’s IndustryAdvantage approach combines industry insights, emerging technologies, and a powerful network of alliance partners to help turn ambition into measurable impact.
As increasing patient demands clash with outdated operations and clinical care models, the Life Sciences & Health Care industry is faced with reimagining how health is delivered, financed and experienced.
Deloitte’s IndustryAdvantage approach is designed to progress the evolution of health. Combining sector knowledge, advanced technologies, strategic alliances and regulatory insights, we accelerate the journey from scientific discovery to patient impact. This way, leaders can focus on the health of patients and communities.
The result? A health system that's more connected and responsive to patients and frees clinicians and researchers to focus their time on improving health outcomes.
This report explores how cross-sector, place-based coalitions align stakeholders, capabilities and resources to turn ambition into action, using NCD outcomes as a use case.
Welcome to the 16th edition of Measuring the return from pharmaceutical innovation. This year, the analysis shows an industry at an inflection point.
Welcome to the fourth of a series of life sciences and healthcare predictions reports, comprising ten predictions exploring how the world could look in 2030, what it might feel like for different stakeholders in the health ecosystem, the evidence today that informs our views of tomorrow and how AI technologies, specifically GenAI, might help to bring the future closer.
Platform businesses are rewiring the traditional value chain. In nearly every industry, well-thought-out platform businesses typically beat traditional businesses because of superior unit economics and network effects.